2 completed, 2 terminated, 2 unknown, 1 not yet recruiting. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 2, Terminated 2, Unknown 2, Not yet recruiting 1 |
Follow Cholangitis: new trials by email Literature Review of Cholangitis trials Research Report on Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rifaximin for Prevention of Recurrent Mild-to-moderate Ascending Cholangitis After Biliary-enteric Anastomosis Rifaximin combined with standard care, Standard Care (in control arm) - Cholangitis, Ascending Cholangitis | Phase 4 | Not yet recruiting | Ruijin Hospital | 60 | 2026-10-01 | 2026-10-30 |
| Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy Sulperazon, Teicoplanin, Meropenem Injection - Cholangitis, Secondary Biliary, Treatment Compliance | Phase 4 | Completed | Tongji Hospital | 160 | 2021-05-01 | 2022-04-11 |
| Antibiotics to Decrease Post ERCP Cholangitis Ceftriaxone, Levofloxacin - Cholangitis | Phase 4 | Unknown | University of Southern California | 200 | 2017-03-29 | 2023-03-06 |
| Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Vancomycin, Placebo - Primary Sclerosing Cholangitis | Phase 4 | Unknown | Tehran University of Medical Sciences | 30 | 2015-09-01 | 2015-11-16 |
| Deescalating Carbapenems in Hospital Setting Deescalation therapy, Maintaining carbapenem therapy - Urinary Infection, Digestive Infection | Phase 4 | Terminated | Assistance Publique - Hôpitaux de Paris | 6 | 2015-06-01 | 2017-02-23 |
| The INFECIR-2 Albumin Prevention Study Albumin - Advanced Chronic Liver Disease, Urinary Infection | Phase 4 | Terminated | EASL - CLIF Consortium | 136 | 2014-05-01 | 2017-05-18 |
| DGT Versus TPS in Patients With Initial PD Cannulation by Chance; Prospective Multi-center Study Tracer Hybrid® Wire Guides, Tracer Metro® Direct™ Wire Guide - Pancreatitis, Cholangitis | Phase 4 | Completed | Soon Chun Hyang University | 111 | 2005-01-01 | 2012-12-07 |
Urinary Tract Infections (2) · Biliary Atresia (1) · Cholangitis, Sclerosing (1) · Cholecystitis (1) · Fibrosis (1) · Liver Cirrhosis, Biliary (1) · Pancreatitis (1) · Patient Compliance (1) · Pneumonia (1)
Bile Duct Diseases (7) · Biliary Tract Diseases (7) · Digestive System Diseases (7) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Infections (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Behavior (1) · Cholestasis (1) · Cholestasis, Intrahepatic (1)
Albumins (1) · Ceftriaxone (1) · Levofloxacin (1) · Meropenem (1) · Standard of Care (1) · Teicoplanin (1) · Tinidazole (1) · Vancomycin (1) · sulperazone (1)
Assistance Publique - Hôpitaux de Paris (1) · EASL - CLIF Consortium (1) · Ruijin Hospital (1) · Soon Chun Hyang University (1) · Tehran University of Medical Sciences (1) · Tongji Hospital (1) · University of Southern California (1)
China (1) · Iran (1) · South Korea (1) · Spain (1) · United States (1)
Agustin Albillos (1) · Aide McCormick (1) · Alexander Gerbes (1) · Andrea de Gottardi (1) · Carlo Alessandria (1) · Faouzi Saliba (1) · Feng Jiexiong, Postdoctoral (1) · Fin Stolze Larsen (1) · Francesco Salerno (1) · Frederick Nevens (1) · German Soriano (1) · Henning Gronbaeck (1) · James Buxbaum (1) · Javier Fernandez (1)
PMID 15557948, PMID 17509029, PMID 17696583, PMID 18061594, PMID 18462108, PMID 19238021, PMID 19286178, PMID 20927758, PMID 21692712, PMID 21835401, PMID 2209498, PMID 23307001, PMID 25442089, PMID 31394283, PMID 37678274, PMID 8779455